Evolocumab Biosimilar - Anti-PCSK9 mAb - Research Grade
Source
CAS 1256937-27-5
Species
Homo sapiens
Expression system
Mammalian cells
Molecular weight
144kDa
Purity
>85%
Buffer
PBS buffer PH7.5
Delivery condition
Blue ice (+4°C)
Delivery Time
3-5 days if in stock; 3-5 weeks if production needed
Storage condition
store at -80°C
Brand
ProteoGenix
Aliases /Synonyms
Evolocumab,AMG 145,Anti-PCSK9,PCSK9,anti-PCSK9
Reference
PX-TA1307
Note
For research use only. Not suitable for clinical or therapeutic use.
Isotype
IgG2-lambda
Clonality
Monoclonal Antibody
Description of Evolocumab Biosimilar - Anti-PCSK9 mAb - Research Grade
General information on Anti-PCSK9[Homo sapiens] (Evolocumab) Monoclonal Antibody
Evolocumab is a human IgG2 monoclonal antibody that binds to and prevents the binding of the proprotein convertase subtilisin/kexin type 9 (PCSK9). PCSK9 is a protein that binds to LDL receptors for degradation, thus reducing the liver’s activity of removal of LDL-cholesterol (LDL-C) from the blood. It is used in the treatment of hyperlipidemia.
SDS-PAGE for Evolocumab Biosimilar - Anti-PCSK9 mAb
Evolocumab Biosimilar - Anti-PCSK9 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Reviews
There are no reviews yet.
REVIEW YOUR PRODUCT
Be the first to review “Evolocumab Biosimilar – Anti-PCSK9 mAb – Research Grade” Cancel reply
Reviews
There are no reviews yet.